Acro Biomedical Co Ltd reported break-eaven for the III. Quarter compare to net loss per share of $-0.05 recorded in the same quarter a year ago an improvement compare to $0.00 realized in previous quarter.
III. Quarter
Earnings Per Share
Revenues
$ 0
$
0 Mill
$+0.05
Unch.
Acro Biomedical Co Ltd 's Revenue
fell by
0 % in III. Quarter (Sep 30 2022) year on year,
to $0 million and
declined by
sequentially.
Acro Biomedical Co Ltd is Expected to report next financial results on April 14, 2023.
Acro Biomedical Co Ltd 's
in III. Quarter recorded net loss of $-4.011 million, an increase from net loss of $-2.991 million in III. Quarter a year ago.
Inventories declined by -33.93 % to $0.30 million from III. Quarter a year ago, sequentially inventories fell by 0 %.
ACBM's Cash flow
In III. Quarter company's net cash flow was $0 million
